,i #aahth ,,congress #ast ,session ,h4 ,r4 #ccge ,,in ,,the ,,house ,,of ,,representatives ,may #af1 #bjbc,ms4 ,kuster 7for herself1 ,ms4 ,blunt ,rochester1 ,mr4 ,bacon1 ,mr4 ,tonko1 ,mr4 ,trone1 ,mr4 ,panetta1 ,mrs4 ,trahan1 ,mr4 ,allred1 ,ms4 ,craig1 ,ms4 ,pettersen1 ,ms4 ,barragn1 and ,mr4 ,norcross7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids1 and for other purposes4 #a4 ,short title2 table of contents 7a7 ,short title ,this ,act may be cited as the ,support1 ,treatment1 and ,overdoses ,prevention of ,fentanyl ,overdoses ,act of #bjbc or the ,,stop ,fentanyl ,overdoses ,act of #bjbc4 7b7 ,table of contents ,the table of contents for this ,act is as follows3 ,sec4 #a4 ,short title2 table of contents4,sec4 #b4 ,definitions4,title ,i--,improving ,fentanyl ,surveillance,sec4 #aja4 ,enhanced drug surveillance4,sec4 #ajb4 ,collection of overdose data4,sec4 #ajc4 ,public health support for law enforcement4,sec4 #ajd4 ,fentanyl detection4,sec4 #aje4 ,grants to improve public health surveillance in forensic laboratories4,title ,,ii--,stemming the ,supply of ,fentanyl,sec4 #bja4 ,report on countries that produce synthetic drugs4,sec4 #bjb4 ,,gao report on international mail and cargo screening4,title ,,iii--,overdose ,prevention and ,substance ,use ,disorder ,treatment ,programs,sec4 #cja4 ,opioid treatment education4,sec4 #cjb4 ,study on naloxone access4,sec4 #cjc4 ,increasing access to medication for opioid overdose reversal4,sec4 #cjd4 ,grant program on harms of drug misuse4,sec4 #cje4 ,good ,samaritan immunity4,sec4 #cjf4 ,report on overdose prevention centers4,sec4 #cjg4 ,prisons and substance use disorder treatment4 #b4 ,definitions ,in this ,act1 except as otherwise provided3 7#a7 ,the term ,assistant ,secretary means the ,assistant ,secretary for ,mental ,health and ,substance ,use4 7#b7 ,the term ,secretary means the ,secretary of ,health and ,human ,services4 7#c7 ,the term fentanyl-related substance has the meaning given the term in section #acjh4aa7;h77#cj77;i7 of title #ba1 ,code of ,federal ,regulations 7or successor regulations74 ,i ,improving ,fentanyl ,surveillance #aja4 ,enhanced drug surveillance 7a7 ,,cdc surveillance program ,title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bda et seq47 is amended by inserting after section #cag,v of such ,act 7#db ,u4,s4,c4 #bdg;b-#bd7 the following3 #cag,w4 ,enhanced drug surveillance 7a7 ,in general ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 shall enhance the ,overdose ,data to ,action drug surveillance program of the ,centers and other drug surveillance programs by-- 7#a7 encouraging ,states1 political subdivisions of ,states1 and territories to participate2 7#b7 increasing and accelerating the collection of data on fentanyl1 fentanyl-related substances1 other synthetic opioids1 and new emerging drugs of use 7including harmful adulterants of fentanyl such as xylazine71 including the collection of related overdose data from medical examiners and drug treatment admissions and information regarding drug seizures2 and 7#c7 utilizing available and emerging information on fentanyl1 fentanyl-related substances1 other synthetic opioids1 and new emerging drugs of abuse1 including information from-- 7,a7 the ,high ,intensity ,drug ,trafficking ,areas program2 7,b7 the ,national ,drug ,early ,warning ,system2 7,c7 ,state and local public health authorities2 7,d7 ,federal1 ,state1 and local public health laboratories2 and 7,e7 drug seizures by ,federal1 ,state1 and local law enforcement agencies1 including information from the ,national ,seizure ,system and the ,national ,forensic ,laboratory ,information ,system of the ,drug ,enforcement ,administration4 7b7 ,information sharing ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 shall publicly disseminate findings collected through the ,overdose ,data to ,action drug surveillance program of the ,centers for ,disease ,control and ,prevention4 7c7 ,definition ,in this section1 the term fentanyl-related substance has the meaning given the term in section #acjh4aa7;h77#cj77;i7 of title #ba1 ,code of ,federal ,regulations 7or successor regulations74 4 7b7 ,law enforcement reporting ,each ,federal law enforcement agency shall report information on all drug seizures by that agency to the ,drug ,enforcement ,administration for inclusion in the ,national ,seizure ,system4 7c7 ,,gao report ,not later than #b years after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall-- 7#a7 publish a report analyzing how ,federal agencies can improve their collection1 reporting1 sharing1 and analytic use of drug seizure data across ,federal agencies and with ,state and local governments2 and 7#b7 include in such report an analysis of how well available data on drug seizures can measure progress toward reducing drug trafficking into and within the country1 as outlined in strategies such as the ,national ,drug ,control ,strategy of the ,office of ,national ,drug ,control ,policy4 #ajb4 ,collection of overdose data 7a7 ,in general ,not later than #b years after the date of enactment of this ,act1 the ,secretary shall commence a study on how to most efficiently track overdoses by type of drug1 including fentanyl4 7b7 ,grant program 7#a7 ,in general ,upon completion of the study under subsection 7a71 and taking into consideration the results of such study1 the ,secretary shall award grants to ,states to facilitate the collection of data with respect to fentanyl-involved overdoses4 7#b7 ,requirement ,as a condition on receipt of a grant under this subsection1 an applicant shall agree to share the data collected pursuant to the grant with the ,centers for ,disease ,control and ,prevention4 7#c7 ,preference ,in awarding grants under this subsection1 the ,secretary shall give preference to applicants whose grant proposals demonstrate the greatest need for collecting timely and accurate data on overdoses4 #ajc4 ,public health support for law enforcement 7a7 ,support for fentanyl detection and handling ,the ,secretary1 in consultation with the ,attorney ,general1 shall carry out a program to provide to ,federal1 ,state1 and local law enforcement agencies training on accurate information about fentanyl and how to detect and handle fentanyl4 7b7 ,evidence-,based ,the program under subsection 7a7 shall comply with evidence-based guidelines1 including the ,fentanyl ,safety ,recommendations for ,first ,responders 7or any successor guidelines7 of the ,office of ,national ,drug ,control ,policy4 #ajd4 ,fentanyl detection 7a7 ,testing of contaminants ,the ,secretary1 acting through the ,assistant ,secretary and in coordination with the ,director of the ,centers for ,disease ,control and ,prevention1 shall continue to improve efforts to enhance screening and identification of contaminants in drugs to prevent overdoses4 7b7 ,research into technologies ,the ,secretary shall conduct or support research for the development or improvement of portable and affordable technologies related to checking drugs for fentanyl and fentanyl-related substances1 including chemical screening device methods4 #aje4 ,grants to improve public health surveillance in forensic laboratories ,title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#cd ,u4,s4,c4 #ajaja et seq47 is amended by adding at the end the following3 ,,pp ,confronting the use of heroin1 fentanyl1 and associated synthetic drugs #cjfa4 ,grants to address public safety through improved forensic laboratory data 7a7 ,purpose ,the purpose of a grant awarded under this section shall be to promote public health by assisting a ,state or unit of local government-- 7#a7 establish or improve a surveillance program in order to facilitate the seizure of covered controlled substances2 and 7#b7 carry out the activities described in section #aja of the ,,stop ,fentanyl ,overdoses ,act of #bjbc4 7b7 ,establishment of grant ,the ,attorney ,general1 acting through the ,director of the ,bureau of ,justice ,assistance1 may make a grant to a ,state or unit of local government to promote public health by establishing or improving a surveillance program in order to facilitate the seizure of covered controlled substances4 7c7 ,eligible projects ,a grant awarded under this section shall be used for a program1 project1 or other activity to-- 7#a7 reimburse a ,state1 local1 or other forensic science laboratory for costs associated with testing to help address any backlog of untested samples of covered controlled substances2 7#b7 reimburse a ,state1 local1 or other forensic science laboratory for the procurement of equipment1 technology1 or other support systems2 7#c7 reimburse ,state1 local1 or other forensic science laboratory for improved1 real time data exchange with the ,centers for ,disease ,control and ,prevention on covered controlled substances2 and 7#d7 support a ,state or local health departments deployed to address the use of covered controlled substances4 7d7 ,additional requirement ,a program1 project1 or other activity pursuant to subsection 7c77#b7 shall require that the ,state1 unit of local government1 or ,tribe demonstrate1 to the satisfaction of the ,attorney ,general1 that any reimbursement would result in improved efficiency of laboratory testing and help prevent future backlogs4 7e7 ,allocation 7#a7 ,population allocation ,seventy-five percent of the amount made available to carry out this section in a fiscal year shall be allocated to each ,state or unit of local government that meets the requirements of section #bhjb so that each ,state or unit of local government shall receive an amount that bears the same ratio to the #ge percent of the total amount made available to carry out this section for that fiscal year as the population of the ,state or unit of local government bears to the population of all ,states or units of local governments4 7#b7 ,discretionary allocation ,twenty-five percent of the amount made available to carry out this section in a fiscal year shall be allocated pursuant to the discretion of the ,attorney ,general for competitive grants to ,states or units of local government with high rates of primary treatment admissions for polysubstance use1 including for covered controlled substances1 for use by ,state1 local1 or ,tribal law enforcement agencies4 7#c7 ,limitation ,not less than #fj percent of any amounts made available to carry out this section shall be awarded for a program1 project1 or other activity under paragraph 7#a7 or 7#b7 of subsection 7c74 7#d7 ,minimum requirement ,notwithstanding paragraphs 7#a71 7#b71 and 7#c71 each ,state receiving funds shall not receive less than #j4f percent of the amount made available to carry out this section in each fiscal year4 7f7 ,covered controlled substance defined ,in this section1 the term covered controlled substance means heroin1 fentanyl1 a fentanyl-related substance1 and any associated synthetic drug4 4 ,,ii ,stemming the ,supply of ,fentanyl #bja4 ,report on countries that produce synthetic drugs ,not later than one year after the date of enactment of this ,act1 the ,secretary of ,state shall submit to the ,committee on ,energy and ,commerce of the ,house of ,representatives and the ,committee on the ,judiciary of the ,senate a report-- 7#a7 identifying the countries the ,secretary determines are the principal producers of synthetic drugs trafficked into the ,united ,states2 7#b7 assessing how and why those countries are producing such drugs2 and 7#c7 describing measures the ,secretary plans to take to reduce the flow of such drugs into the ,united ,states4 #bjb4 ,,gao report on international mail and cargo screening ,not later than one year after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit to the ,congress a report reviewing the impact of ,high ,intensity ,drug ,trafficking ,areas program on illicit fentanyl and fentanyl-related substances imported through international mail and cargo1 including discussion of the following3 7#a7 ,the volume of fentanyl and fentanyl-related substances being imported into the country by means of international mail and cargo4 7#b7 ,the potential impact of increased screening for illicit fentanyl and fentanyl-related substances on-- 7,a7 deterring drug trafficking in the ,united ,states2 7,b7 interdicting fentanyl and fentanyl-related substances that were manufactured outside of the ,united ,states and intended1 or attempted1 to be imported into the ,united ,states2 7,c7 the number of ,federal criminal prosecutions based on the manufacture1 distribution1 or possession of fentanyl or fentanyl-related substances1 disaggregated by demographic data1 including sex1 race1 and ethnicity1 of the offender2 7,d7 the charges brought in such prosecutions2 7,e7 the impacts of prosecutions on reducing demand and availability to users2 and 7,f7 the development of new fentanyl-related substances4 7#c7 ,the need for non-invasive technology in screening for fentanyl and fentanyl-related substances1 taking into account the findings pursuant to paragraphs 7#a7 and 7#b74 ,,iii ,overdose ,prevention and ,substance ,use ,disorder ,treatment ,programs #cja4 ,opioid treatment education ,part ,d of title ,v of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;dd et seq47 is amended by adding at the end the following3 #eec4 ,opioid treatment education 7a7 ,in general ,the ,secretary shall award grants to ,states and local governmental entities to provide education to stakeholders1 including health care providers1 criminal justice professionals1 and substance use disorder treatment personnel1 on the current state of research on treatment for opioid use disorder1 including-- 7#a7 the use of opioid agonists or partial agonists2 and 7#b7 the potential benefits of the use of opioid agonists or partial agonists for affected individuals4 7b7 ,report ,not later than one year after the date of enactment of the ,,stop ,fentanyl ,overdoses ,act of #bjbc1 the ,secretary shall submit a report to the ,committee on ,energy and ,commerce of the ,house of ,representatives and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate1 including the following data3 7#a7 ,the number of people reached by educational materials funded pursuant to this section4 7#b7 ,the geographic areas where people received such educational materials4 7#c7 ,the remaining populations and areas targeted for awareness of educational materials1 including the characteristics of such populations and areas such as the type of stakeholder and geographic area4 7#d7 ,the select outcomes of education funded pursuant to this section as determined by the ,secretary4 4 #cjb4 ,study on naloxone access 7a7 ,in general ,the ,comptroller ,general of the ,united ,states shall conduct a study on actions that may be taken to ensure appropriate access and affordability of naloxone for individuals seeking to purchase naloxone4 ,such study shall address what is known about-- 7#a7 coverage of naloxone 7in any available form71 including whether naloxone can be covered as an over-the-counter drug under a group health plan or group or individual health insurance coverage 7as such terms are defined in section #bgia of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#ia77 or for individuals entitled to benefits under part ,a or enrolled under part ,b of title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #acie et seq47 or receiving medical assistance under a ,state plan under title ,,xix of such ,act 7#db ,u4,s4,c4 #acif et seq47 or a waiver of such plan2 7#b7 the out-of-pocket cost to consumers purchasing naloxone-- 7,a7 with a prescription1 with and without coverage under any such plan or coverage2 7,b7 over-the-counter1 with and without coverage under any such plan or coverage2 and 7,c7 pursuant to a standing order2 and 7#c7 other factors impacting coverage1 including barriers in covering naloxone as an over-the-counter drug1 the relative net costs of naloxone when purchased over-the-counter without insurance coverage compared to when purchased with a prescription and covered under a group health plan or health insurance coverage1 and the availability of naloxone purchased and distributed through public health entities4 7b7 ,report ,not later than #b years after the date of the enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit to ,congress a report that contains the findings of the study conducted under subsection 7a74 #cjc4 ,increasing access to medication for opioid overdose reversal 7a7 ,transactions ,section #eha7bd77;,b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;eee7#bd77;,b77 is amended-- 7#a7 by redesignating clauses 7xvii7 and 7xviii7 as clauses 7xviii7 and 7xix71 respectively2 and 7#b7 by inserting after clause 7xvi7 the following3 7xvii7 the distribution of an opioid antagonist indicated for emergency treatment of opioid overdose1 such as naloxone1 by or to an overdose prevention1 syringe services program1 or other harm reduction service2 4 7b7 ,wholesale distribution ,section #ejc7;e77#d7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cec7;e77#d77 is amended-- 7#a7 by redesignating subparagraphs 7,r7 and 7,s7 as subparagraphs 7,s7 and 7,t71 respectively2 and 7#b7 by inserting after subparagraph 7,q7 the following3 7,r7 the distribution of an opioid antagonist indicated for emergency treatment of opioid overdose1 such as naloxone1 by or to an overdose prevention1 syringe services program1 or other harm reduction service2 4 #cjd4 ,grant program on harms of drug misuse ,part ,d of title ,v of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bij;dd et seq471 as amended by section #cja1 is further amended by adding at the end the following3 #eed4 ,grant program on harms of drug misuse 7a7 ,in general ,the ,assistant ,secretary1 in consultation with the ,director of the ,centers for ,disease ,control and ,prevention1 shall award grants to ,states and political subdivisions of ,states to support the delivery of overdose prevention services1 including distribution of ,food and ,drug ,administration-approved opioid reversal agents such as naloxone1 fentanyl strips1 and other harm reduction services that address the harms of drug misuse1 including by-- 7#a7 connecting individuals at risk for1 or with1 a substance use disorder to overdose education1 counseling1 and health education2 and 7#b7 encouraging such individuals to take steps to reduce the harms associated with substance misuse4 7b7 ,considerations ,in awarding grants under this section1 the ,assistant ,secretary shall prioritize grants to applicants that are-- 7#a7 organizations providing culturally competent care in terms of considerations based on race1 language1 ethnicity1 gender1 sexuality1 or disability2 or 7#b7 proposing to serve areas with-- 7,a7 a higher proportion of the population who meet criteria for dependence on1 or abuse of1 illicit drugs2 7,b7 a higher drug overdose death rate2 and 7,c7 a greater behavioral health and substance use disorder workforce need4 7c7 ,special considerations ,a recipient of a grant under this section for the purposes described in subsection 7a77#b7 shall provide overdose prevention services1 as follows3 7#a7 ,ensure that not less than #fj percent of the grant funds are used for harm reduction programs4 7#b7 ,prioritize the delivery of opioid antagonists to-- 7,a7 people who use opioids or illicit drugs2 7,b7 families of such people2 7,c7 first responders such as law enforcement personnel and nonemergency services such as fire fighters and park rangers2 and 7,d7 community service providers1 such as library1 school1 and public transportation personnel4 7d7 ,use of grant awards ,a recipient of a grant under this section may use grant funds for the following3 7#a7 ,adapting1 maintaining1 and expanding essential services provided by harm reduction service organizations to address the risks of drug overdose and contraction of infectious disease4 7#b7 ,maintaining or hiring staff4 7#c7 ,supporting program operational costs1 including staff1 rent1 and vehicle purchase or maintenance4 7#d7 ,program supplies4 7#e7 ,support and case management services4 4 #cje4 ,good ,samaritan immunity 7a7 ,in general ,part ,b of title ,,ii of the ,public ,health ,service ,act is amended by inserting after section #bdh of such ,act 7#db ,u4,s4,c4 #bchq7 the following3 #bdi4 ,good ,samaritan immunity 7a7 ,limitation on civil liability for individuals who administer opioid overdose reversal drugs 7#a7 ,in general ,notwithstanding any other provision of law1 except as provided in paragraph 7#b71 no individual shall be liable in any ,federal or ,state proceeding for harm caused by the emergency administration of an opioid overdose reversal drug to an individual who has or reasonably appears to have suffered an overdose from heroin or another opioid1 if the individual who administers the opioid overdose reversal drug does so in good faith4 7#b7 ,exception ,paragraph 7#a7 shall not apply to an individual if the harm was caused by the gross negligence or reckless misconduct of the individual who administers the drug4 7#c7 ,definitions ,in this subsection3 7,a7 ,the term health care professional means a person licensed by a ,state to prescribe prescription drugs4 7,b7 ,the term opioid overdose reversal drug means a drug approved under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act that is indicated for the partial or complete reversal of the pharmacological effects of an opioid overdose in the human body4 7,c7 ,the term opioid overdose prevention program means a program operated by a local health department1 harm reduction or other community-based organization1 substance abuse treatment organization1 law enforcement agency1 fire department1 other first responder department1 or voluntary association1 or a program funded by a ,federal1 ,state1 or local government1 that works to prevent opioid overdoses by in part providing opioid overdose reversal drugs and education-- 7i7 to individuals at risk of experiencing an opioid overdose2 or 7ii7 to an individual in a position to assist another individual at risk of experiencing an opioid overdose4 7b7 ,immunity from liability 7#a7 ,in general ,an individual who1 in good faith and in a timely manner-- 7,a7 seeks medical assistance for another individual who is experiencing a drug overdose1 or 7,b7 seeks medical assistance for himself or herself for a drug overdose1 or is the subject of a request for medical assistance described in subparagraph 7,a71 shall not be cited1 arrested1 prosecuted1 criminally liable1 or subject to any sanction for a violation of a condition of supervised release under section #djd of the ,controlled ,substances ,act for the possession or use of a controlled substance1 or under any other provision of ,federal law regulating the misuse of prescription drugs1 as a result of seeking such medical assistance4 7#b7 ,preemption ,this subsection preempts the laws of a ,state or any political subdivision of a ,state to the extent that such laws are inconsistent with this section1 unless such laws provide greater protection from liability4 7#c7 ,definitions ,in this section3 7,a7 ,the term controlled substance has the meaning given the term in section #ajb of the ,controlled ,substances ,act4 7,b7 ,the term drug overdose means an acute condition resulting from or believed to be resulting from the use of a controlled substance1 which an individual1 who is not a health care professional1 would reasonably believe requires medical assistance4 7,c7 ,the term prescription drug means a drug subject to section #ejc7;b77#a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act4 7,d7 ,the terms seeks medical assistance and seeking such medical assistance include-- 7i7 reporting a drug or alcohol overdose or other medical emergency to a law enforcement authority1 the #i-a-a system1 a poison control center1 or a medical provider2 7ii7 assisting another individual who is making a report described in clause 7i72 or 7iii7 providing care to someone who is experiencing a drug or alcohol overdose or other medical emergency while awaiting the arrival of medical assistance4 4 7b7 ,public awareness campaign ,the ,secretary of ,health and ,human ,services1 in coordination with the ,administrator of the ,drug ,enforcement ,administration1 shall carry out a campaign to increase public awareness of the limitations on civil and criminal liability established by section #bdi of the ,public ,health ,service ,act1 as added by subsection 7a74 #cjf4 ,report on overdose prevention centers ,the ,secretary of ,health and ,human ,services shall enter into appropriate arrangements with the ,national ,academies of ,sciences1 ,engineering1 and ,medicine under which the ,academies agree to-- 7#a7 not later than two years after the date of enactment of this ,act1 submit to the ,congress a report on overdose prevention centers2 and 7#b7 include in such report-- 7,a7 identification of barriers to operating overdose prevention centers2 7,b7 a compilation of the data available to measure effectiveness of overdose prevention centers on reducing overdose deaths1 and improving access to medication for opioid use disorder and recovery services2 7,c7 identification of best practices to promote individual and community public health1 provide resources to individuals and families1 improve access to substance use disorder and behavioral health services1 and reduce stigma2 7,d7 recommendations for developing integrated care settings inclusive of overdose prevention sites and incorporating overdose prevention sites into referral networks2 and 7,e7 approaches to overdose prevention services that may serve as effective strategies for recovery for people using fentanyl4 #cjg4 ,prisons and substance use disorder treatment 7a7 ,prisons and medication-,assisted treatment ,the ,director of the ,bureau of ,prisons1 in collaboration with the ,director of the ,office of ,national ,drug ,control ,policy1 shall establish a program to offer to individuals in the custody of the ,bureau of ,prisons-- 7#a7 drugs that are approved by the ,food and ,drug ,administration for treatment of a substance use disorder2 7#b7 counseling and other psychosocial treatments for the treatment of substance use disorders2 and 7#c7 evidence-based withdrawal management services4 7b7 ,residential substance abuse treatment for ,state prisoners ,section #aijd7;d7 of title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#cd ,u4,s4,c4 #ajdbd7;d77 is amended-- 7#a7 by striking means and inserting the following3 7#a7 means 2 7#b7 by striking the period at the end and inserting 2 and2 and 7#c7 by adding at the end the following3 7#b7 includes any drug approved by the ,food and ,drug ,administration for the treatment of substance use disorder4 4